Methylglyoxal‐derived hydroimidazolone ( MG ‐ H1 ) is a novel marker of insulin resistance in Japanese individuals, disturbing insulin signalling via mTORC2 in cultured myocytes
Diabetes, Obesity and Metabolism · 2026
DOI: 10.1111/dom.70489 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Sonoko Kitao und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Multidisciplinary Internal Medicine, Department of Endocrinology and Metabolism, School of Medicine, Faculty of Medicine, Tottori Univers…. Hauptthemen laut MEDLINE: Insulin Resistance, Diabetes Mellitus, Type 2, Imidazoles, Mechanistic Target of Rapamycin Complex 2. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Background and Aims Methylglyoxal‐derived hydroimidazolone (MG‐H1), one of the advanced glycation end‐products (AGEs), has been a potential biomarker of type 2 diabetes (T2DM), which is strongly related to insulin resistance. However, the relationship between the dynamics of MG‐H1 and insulin resistance has not been characterized, and its mechanism on insulin resistance is unknown. In this study, we aimed to investigate the relationship between MG‐H1 and insulin resistance in the clinical study of Japanese individuals and identify the molecular mechanisms underlying MG‐H1 associated phenomena in vitro.
Methods
We performed the meal tolerance test (MTT) and hyper‐insulinemic–euglycemic clamp analysis in 19 patients with T2DM and 19 participants without diabetes (non‐DM). We measured their fasting and postprandial MG‐H1 using liquid chromatography–tandem mass spectrometry (LC–MS/MS). In addition, we evaluated the effects of MG‐H1 on glucose uptake and insulin signalling in C2C12 skeletal myocytes.
Results
The postprandial MG‐H1 and the area under the curve (AUC) of MG‐H1 in MTTs were significantly negatively correlated with the glucose disposal rate (GDR) in clamp studies both in the T2DM ( r = −0.72 [ p < 0.001]) and non‐DM ( r = −0.54 [ p < 0.05]) groups. In cultured C2C12 skeletal myocytes, pre‐treatment with MG‐H1 inhibited insulin‐stimulated phosphorylation of Akt and glucose uptake, via the activation of mechanistic target of rapamycin complex 2 (mTORC2).
Conclusions
In clinical study findings revealed that postprandial MG‐H1 was a novel marker of insulin resistance in Japanese individuals, and in vitro findings using cultured C2C12 skeletal myocytes suggested that MG‐H1 disturbs insulin signalling via the mechanisms of mTORC2 activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Multidisciplinary Internal Medicine, Department of Endocrinology and Metabolism, School of Medicine, Faculty of Medicine, Tottori University, Yonago, Japan.
- Division of Pharmacology, Department of Pathophysiological and Therapeutic Sciences, School of Medicine, Faculty of Medicine, Tottori University, Yonago, Japan.
- Faculty of Applied Life Sciences, Niigata University of Pharmacy and Medical and Life Sciences, Niigata, Japan.
- School of Health Science, Tottori University Faculty of Medicine, Yonago, Japan.
- Ochanomizu University, Tokyo, Japan.
- Department of Community-based Family Medicine, Tottori University Faculty of Medicine, Yonago, Japan.
ORCID-Profile: Sonoko Kitao, Tsuyoshi Okura
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Kitao, S., Okura, T., Ito, Y., Endo, S., Ichihara, Y., Sawano, T., Nakamura, R., Matsuzawa, K., Nomi, Y., Ueta, E., Otsuka, Y., Nagata, K., Miake, J., Taniguchi, S. I., Yamamoto, K., & Imamura, T. (2026). Methylglyoxal‐derived hydroimidazolone ( MG ‐ H1 ) is a novel marker of insulin resistance in Japanese individuals, disturbing insulin signalling via mTORC2 in cultured myocytes. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70489
Vancouver
Kitao S, Okura T, Ito Y, Endo S, Ichihara Y, Sawano T, et al. Methylglyoxal‐derived hydroimidazolone ( MG ‐ H1 ) is a novel marker of insulin resistance in Japanese individuals, disturbing insulin signalling via mTORC2 in cultured myocytes. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.70489
BibTeX
@article{Kitao2026,
author = {Kitao, Sonoko and Okura, Tsuyoshi and Ito, Yuichi and Endo, Satomi and Ichihara, Yoshinori and Sawano, Tatsuya and Nakamura, Risa and Matsuzawa, Kazuhiko and Nomi, Yuri and Ueta, Etsuko and Otsuka, Yuzuru and Nagata, Keiko and Miake, Junichiro and Taniguchi, Shin-Ichi and Yamamoto, Kazuhiro and Imamura, Takeshi},
title = {Methylglyoxal‐derived hydroimidazolone ( MG ‐ H1 ) is a novel marker of insulin resistance in Japanese individuals, disturbing insulin signalling via mTORC2 in cultured myocytes},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
doi = {10.1111/dom.70489}
}
EUVIMED